LA JOLLA PHARMACEUTICAL CO (LJPC)
US5034596040 - Common Stock
| TTM (2022-6-30) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 3.97M | 19.66M | -39.42M | -116.51M | -199.47M | |||
| Depreciation Amortization | 1.66M | 1.66M | 2.84M | 4.55M | 4.41M | |||
| Change In Working Capital | -346.00K | -5.03M | -17.06M | -6.83M | 510.00K | |||
| Interest Paid | N/A | N/A | N/A | 2.00M | 510.00K | |||
| Other non cash items | 7.86M | 11.95M | 16.01M | 33.84M | 42.18M | |||
| OPERATING CASH FLOW | 13.13M | 28.24M | -37.64M | -84.95M | -152.37M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -9.00K | 0.00 | -700.00K | -2.34M | |||
| Other Investing Activity | 271.00K | 0.00 | -30.95M | N/A | N/A | |||
| INVESTING CASH FLOW | 262.00K | -9.00K | -30.95M | -700.00K | -2.34M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | -10.95M | -2.79M | 1.12M | 860.00K | 112.11M | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | 124.29M | |||
| FINANCING CASH FLOW | -10.95M | -2.79M | 1.12M | 860.00K | 236.40M | |||
| CHANGE IN CASH | 2.45M | 25.45M | -67.47M | -84.79M | 81.69M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 13.13M | 28.24M | -37.64M | -84.95M | -152.37M | |||
| Capital Expenditure | N/A | -9.00K | 0.00 | -700.00K | -2.34M | |||
| FREE CASH FLOW | N/A | 28.23M | -37.64M | -85.65M | -154.71M | |||
All data in USD